https://www.selleckchem.com/pr....oducts/puromycin-ami
In the subgroup of SLE pregnancies with antiphospholipid syndrome, there were higher SLE flare rates (40%) and adverse fetal outcomes occurred in 8 pregnancies (80%). There were no predictive factors identified for all adverse fetal and maternal outcomes. In the subgroup analysis of preterm delivery, anti-Ro (SS-A) antibody positivity and hydroxychloroquine treatment were associated with a lower risk of preterm delivery. Although the majority had quiescent SLE disease activity at baseline, SLE pregnancies were associat
Like
Comment
Share
